Predictors of Good Outcome After Endovascular Treatment for Patients with Vertebrobasilar Artery Occlusion due to Intracranial Atherosclerotic Stenosis

Clin Neuroradiol. 2019 Dec;29(4):693-700. doi: 10.1007/s00062-018-0731-z. Epub 2018 Nov 29.

Abstract

Purpose: To investigate the predictors for good outcome of endovascular therapy (EVT) for patients with acute vertebrobasilar artery occlusion (VBAO) due to intracranial atherosclerosis stenosis (ICAS).

Methods: From April 2012 to February 2018, patients with VBAO due to ICAS who received EVT were retrospectively analyzed. ICAS was defined as fixed stenosis of >70%, or a degree of fixed stenosis >50% in addition to either perfusion impairment or evidence to re-occlusion. Good outcome was defined as mRS≤2 at 90 days. Both logistic regression and receiver operating characteristic curve (ROC) analyses were performed to explore the predictors.

Results: Among 103 patients enrolled in the analysis, 40.8% achieved good outcome. Prior antiplatelet therapy (OR, 7.301; 95% CI, 1.761-30.265; P=0.006), EVT+IVT (OR, 7.343; 95% CI, 1.621-33.263; P=0.010 ), the pc-ASPECT on DWI (OR, 1.705; 95% CI, 1.127-2.580; P=0.012), BATMAN (OR, 1.395; 95% CI, 1.005-1.937; P=0047), general anesthesia (OR, 0.081; 95% CI, 0.010-0.633; P=0.017), onset-to-recanalization time (≤542min vs. >542min) (OR, 0.194; 95% CI, 0.057-0.661; P=0.009) and the initial NIHSS (OR, 0.882; 95% CI, 0.820-0.949; P=0.001) were significantly associated with good outcome in logistic regression. Based on ROC analyses, initial NIHSS score (area under the curve [AUC]= 0.816, p <0.001; cutoff,19.5; sensitivity, 78.7%; specificity, 72.5%) was significant predictors of good outcome.

Conclusions: For patients with VBAO due to ICAS, prior antiplatelet therapy, EVT+IVT, local anesthesia, short onset-to-recanalization time, a low initial NIHSS, a high pc-ASPECT and BATMAN might be helpful to predict the good outcome at 90 days after EVT.

Keywords: Acute ischemic stroke; Antiplatelet therapy; BATMAN; Pc-ASPECT; Thrombectomy.

MeSH terms

  • Aged
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / surgery*
  • Combined Modality Therapy
  • Endovascular Procedures / methods*
  • Female
  • Humans
  • Intracranial Arteriosclerosis / complications*
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Thrombolytic Therapy / methods
  • Treatment Outcome
  • Vertebrobasilar Insufficiency / drug therapy
  • Vertebrobasilar Insufficiency / etiology
  • Vertebrobasilar Insufficiency / surgery*

Substances

  • Platelet Aggregation Inhibitors